Tomoyuki Ohe

p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming

Tetsuya Saito, Yoshinobu Ichimura, Keiko Taguchi et al. · Nature Communications · 2016 · 360 citations · Full text

p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response

Shun Kageyama, Sigurður Guðmundsson, Yu‐shin Sou et al. · Nature Communications · 2021 · 265 citations · Full text

In Vitro Substrate Identification Studies for P-glycoprotein-Mediated Transport: Species Difference and Predictability of in Vivo Results

Masayo Yamazaki, William Neway, Tomoyuki Ohe et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 237 citations

A Typical Y1 Receptor Regulates Feeding Behaviors: Effects of a Potent and Selective Y1 Antagonist, J-115814

Akio Kanatani, M. Hata, Satoshi Mashiko et al. · Molecular Pharmacology · 2001 · 98 citations

A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice

Akane Ishihara, Akio Kanatani, Satoshi Mashiko et al. · Proceedings of the National Academy of Sciences · 2006 · 76 citations · Full text

Associated Parameters, Caloric Restriction, Gastrointestinal Peptide Hormone +19